- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... areas centered around rare diseases and immune disorders. Summary The Manager , Global Oncology Strategic Planning leads the Consolidation of Revenue Forecasts… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... executes payer strategies and tactics to ensure inline product and pipeline product success and appropriate reimbursement placement In partnership with… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... research areas centered around rare diseases and immune disorders.Summary The Manager , Regulatory Affairs - Regulatory Project Management (RPM) provides planning and… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... with key stakeholder and congress leads to influence decision related to pipeline , disease awareness and commercial brands execution at oncology congresses- Develop… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... team on all aspects of statistical activities; collaborates closely with data manager to ensure high quality data. Work closely with internal statistical… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... centered around rare diseases and immune disorders. Summary The Manager FP&A position is an integral part of the...bring value to our business partners and organization. The Manager FP&A will lead the Annual Financial Plan, Quarterly… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... areas centered around rare diseases and immune disorders. Summary: Manager , Sales Training and Development - Oncology serves as...interaction with vendors and key senior stakeholders at Sr manager and director level in sales, sales training, and… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... setting, to drive the development of potential products and drug candidates. The Manager , Clinical Pharmacology will support or take the lead on generation of study… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... around rare diseases and immune disorders. Job Summary The Biosample Operations Manager , Biosample Management is responsible for supporting the oversight of the… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... areas centered around rare diseases and immune disorders. SummaryAs a Manager , Generative AI, you will be responsible for conceptualizing, developing, implementing,… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... service disruption is required.- Strategic Planning- Under the guidance of the Manager develop and implement business operational strategies that align with the… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... as other research areas centered around rare diseases and immune disorders.Summary The Manager of Data Governance Stewardship will work in areas required for the… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... colleagues on the outsourcing process and procedures. (not a formal people manager ). Develops detailed bid analysis for the RD functional group's review. Development… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... and factoring regional needs, laws, and requirements.- Collaborate with the Project Manager (PM), HCP Engagement IT Operations team and business stakeholders to… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group's 2025 Vision to ... become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.Summary Manage Global DX… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio ... of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas… more
